Date
Sponsor content
1 result(s) found, displaying 1 to 1
-
Prescription medicine decision summaryTGA decision: Teriparatide Lupin and LAPL and GH (teriparatide acetate) are approved for the treatment of osteoporosis.
Regulatory activities for this sponsor.